Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uveal Melanoma × Pharmacogenomic Testing × 1 year × Clear all

Sponsor

Conditions

Neoplasms 2 Waldenstrom Macroglobulinemia 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Solitary Fibrous Tumor, Pleural 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Glioma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Clear Cell 1 Chondrosarcoma 1 Carcinoma, Medullary 1 Cancer Pain 1 Breast Neoplasms 1 Anemia 1 Anatomic Stage III Breast Cancer AJCC v8 1 Adult Patients Who Are Receiving Oncologic Care 1 Adjustment Disorders 1 Adenocarcinoma, Follicular 1

Interventions

Nivolumab 11 Ipilimumab 10 pembrolizumab 8 Cyclophosphamide 5 tebentafusp 4 Interleukin-2 4 Blood Specimen Collection 4 aflibercept 3 Specimen Handling 3 Radiosurgery 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 relatlimab 2 lenvatinib 2 fludarabine phosphate 2 fludarabine 2 cemiplimab 2 binimetinib 2 Surveys and Questionnaires 2 Carmustine 2 CTLA-4 Antigen 2 Biopsy 2 ulixertinib 1 trametinib 1 tislelizumab 1 sargramostim 1 quisinostat 1 omipalisib 1 olaparib 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡